Associated Papers
Association between GPER gene polymorphisms and GPER expression levels with cancer predisposition and progression.
Ulhaq ZS et al.
Heliyon, 2021
A hypertension patient-derived iPSC model demonstrates a role for G protein-coupled estrogen receptor in hypertension risk and development.
Fredette NC et al.
American Journal of Physiology. Cell Physiology, 2020
An exome-wide rare variant analysis of Korean men identifies three novel genes predisposing to prostate cancer.
Oh JJ et al.
Scientific Reports, 2019
A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells.
Pupo M et al.
Oncotarget, 2017
G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studies.
Hussain Y et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2015
GPR30 Gene Polymorphisms Are Associated with Gynecomastia Risk in Adolescents.
Korkmaz HA et al.
Hormone Research in Paediatrics, 2015
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Tang X et al.
Nucleic Acids Research, 2014
25352556 (PubMed )
Supplement: supp_gku1005_nar-01266-met-n-2014-File012.xlsx › TCGA-A8-A0A4-01A.domain
A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women.
Feldman RD et al.
British Journal of Clinical Pharmacology, 2014
Genetic variants of GPER/GPR30, a novel estrogen-related G protein receptor, are associated with human seminoma.
Chevalier N et al.
International Journal of Molecular Sciences, 2014
GPR30 gene polymorphisms are associated with progesterone receptor status and histopathological characteristics of breast cancer patients.
Giess M et al.
The Journal of Steroid Biochemistry and Molecular Biology, 2010
Japanese single nucleotide polymorphism database for 267 possible drug-related genes.
Iida A et al.
Cancer Science, 2006
[SNP collection, pharmacogenomics, and the future of drug therapy].
Iida A et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy, 2002
Select a paper to view details